Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michelle Renee Griffin currently holds 15,625 shares of HTG MOLECULAR DIAGNOSTICS, INC (HTGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michelle Renee Griffin has been a net seller of HTGM stock. They have purchased $0 and sold $5.5M worth of shares.
Michelle Renee Griffin's most recent insider trade was on Jun 25, 2026, when they sold 52,084 shares at $0.00 per share.
Michelle Renee Griffin serves as Executive at HTG MOLECULAR DIAGNOSTICS, INC (HTGM). They have executed 49 insider transactions totaling $5.5M over their tenure at the company.
Michelle Renee Griffin holds the position of Executive at HTG MOLECULAR DIAGNOSTICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Michelle Renee Griffin has shown a selling trading pattern, with $0 in total purchases and $5.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michelle Renee Griffin was on Jun 25, 2026, when they sold $1.1M worth of ADPT shares. This transaction involved 52,084 shares at $20.18 per share.
Michelle Renee Griffin currently owns 15,625 shares of HTG MOLECULAR DIAGNOSTICS, INC (HTGM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michelle Renee Griffin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michelle Renee Griffin has 49 Form 4 filings on record as an insider at HTG MOLECULAR DIAGNOSTICS, INC.
Set alerts for Michelle Renee Griffin and 40,000+ other insiders.